We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Elected officials in Texas have stopped Gov. Rick Perry's executive order requiring all girls ages 11 and 12 to receive a vaccine that prevents cervical cancer. Read More
Sen. Edward Kennedy (D-Mass.) and Rep. John Dingell (D-Mich.) introduced legislation that would expand Medicare by making it available to all American citizens. Read More
The Senate passed a measure easing restrictions on federal funding for embryonic stem cell research that President Bush has vowed to veto if it reaches his desk.
PhRMA voiced opposition to proposed legislation that would create a pathway for the FDA to approve follow-on biologics because it will not ensure patient safety and will hinder innovation, the group said. While PhRMA does support a regulatory pathway for the products, the proposed bill does not ensure the best process for the FDA or consumers, the group added.
Sen. Edward Kennedy (D-Mass.) introduced the Prescription Drug User Fee Act (PDUFA) reauthorization last week, proposing a new structure that would increase the agency’s user fees by more than $100 million.
One of the Democrats' campaign promises took another step forward last week as the Senate Finance Committee approved a bill that would allow the HHS secretary to negotiate prices with companies for Medicare Part D prescription drugs.
PhRMA voiced opposition to proposed legislation that would create a pathway for the FDA to approve follow-on biologics because it will not ensure patient safety and will hinder innovation, the group said.
Faced with soaring healthcare costs driven in part by biopharmaceutical therapies, federal policymakers should give the FDA power to approve follow-on biologics, AARP said.